34 related articles for article (PubMed ID: 11892937)
1. High-throughput determination of enantiopurity in atroposelective synthesis of aryl triazoles.
Lim J; Guo M; Choi S; Miller SJ; Anslyn EV
Chem Sci; 2023 Jun; 14(22):5992-5999. PubMed ID: 37293656
[TBL] [Abstract][Full Text] [Related]
2. Neuroprotective effects of functional antagonists at the glycine site of the NMDA receptor.
Trullas R
Methods Find Exp Clin Pharmacol; 1997; 19 Suppl A():55-6. PubMed ID: 9403859
[No Abstract] [Full Text] [Related]
3. Dantrolene antagonizes the glycineB site of the NMDA receptor.
Salinska E; Sobczuk A; Lazarewicz JW
Neurosci Lett; 2008 Feb; 432(2):137-40. PubMed ID: 18191027
[TBL] [Abstract][Full Text] [Related]
4. Glycine/NMDA receptor antagonists as potential CNS therapeutic agents: ACEA-1021 and related compounds.
Cai SX
Curr Top Med Chem; 2006; 6(7):651-62. PubMed ID: 16719807
[TBL] [Abstract][Full Text] [Related]
5. Pyridazinoquinolinetriones as NMDA glycine-site antagonists with oral antinociceptive activity in a model of neuropathic pain.
Bare TM; Brown DG; Horchler CL; Murphy M; Urbanek RA; Alford V; Barlaam C; Dyroff MC; Empfield JB; Forst JM; Herzog KJ; Keith RA; Kirschner AS; Lee CM; Lewis J; McLaren FM; Neilson KL; Steelman GB; Trivedi S; Vacek EP; Xiao W
J Med Chem; 2007 Jun; 50(13):3113-31. PubMed ID: 17542571
[TBL] [Abstract][Full Text] [Related]
6. UK-315716/UK-240455. Pfizer.
Capelli AM; Micheli F
Curr Opin Investig Drugs; 2001 Dec; 2(12):1737-9. PubMed ID: 11892937
[TBL] [Abstract][Full Text] [Related]
7. Gacyclidine (Beaufour-Ipsen).
Mitha AP; Maynard KI
Curr Opin Investig Drugs; 2001 Jun; 2(6):814-9. PubMed ID: 11572662
[TBL] [Abstract][Full Text] [Related]
8. Tricyclic quinoxalinediones, aza-kynurenic acids, and indole-2-carboxylic acids as in vivo active NMDA-glycine antagonists.
Nagata R; Katayama S; Ohtani K; Tanaka H; Shimago K
Curr Top Med Chem; 2006; 6(7):733-45. PubMed ID: 16719813
[TBL] [Abstract][Full Text] [Related]
9. Paradigm shift in neuroprotection by NMDA receptor blockade: memantine and beyond.
Lipton SA
Nat Rev Drug Discov; 2006 Feb; 5(2):160-70. PubMed ID: 16424917
[TBL] [Abstract][Full Text] [Related]
10. Neramexane (merz pharmaceuticals/forest laboratories).
Rammes G; Schierloh A
IDrugs; 2006 Feb; 9(2):128-35. PubMed ID: 16523403
[TBL] [Abstract][Full Text] [Related]
11. Glutamate-based therapeutic approaches: clinical trials with NMDA antagonists.
Muir KW
Curr Opin Pharmacol; 2006 Feb; 6(1):53-60. PubMed ID: 16359918
[TBL] [Abstract][Full Text] [Related]
12.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
